SymBiosis (Bentonville) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 68

  • Portfolio
  • 24

  • Exits
  • 25

Exits

SymBiosis (Bentonville) General Information

Company Description

Founded in 2021, SymBiosis is a venture capital firm based in Bentonville, Arkansas. The firm prefers to invest in companies operating in the biotherapeutics and advanced manufacturing sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Year Founded
2021
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 609 Southwest 8th Street
  • Suite 510
  • Bentonville, AR 72712
  • United States
+1 (479)

SymBiosis (Bentonville) Investments (68)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
R1 Therapeutics 30-Sep-2026 Early Stage VC Drug Discovery Clinical Trials - Phase 2
AdvanCell 15-Jul-2026 Drug Discovery Clinical Trials - Phase 2
Alebund Pharmaceuticals 29-Jun-2026 Drug Discovery Generating Revenue
SonoThera 08-Jun-2026 Drug Discovery Pre-Clinical Trials
Universal DX 20-May-2026 Diagnostic Equipment Clinical Trials - General
CORXEL Pharmaceuticals 22-Jan-2026 Drug Discovery Generating Revenue
Aeovian Pharmaceuticals 16-Dec-2025 Drug Discovery Generating Revenue
Solve Therapeutics 17-Nov-2025 Drug Discovery Clinical Trials - Phase 1
Tempero Bio 05-Nov-2025 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Alebund Pharmaceuticals 29-Oct-2025 Later Stage VC Drug Discovery Generating Revenue
You’re viewing 10 of 68 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SymBiosis (Bentonville) Exits (25)

Company Name Exit Date Exit Type Exit Size
Parabilis Medicines 10-Jun-2026 IPO
Neurona Therapeutics 02-Jun-2026
Clene 06-May-2026
Metsera 13-Nov-2025
Evommune 06-Nov-2025
Aardvark Therapeutics 13-Feb-2025
Metsera 31-Jan-2025
MaaT Pharma 15-May-2024
Metagenomi Therapeutics 09-Feb-2024 IPO
DermBiont 24-Oct-2023 Later Stage VC
You’re viewing 10 of 25 exits. Get the full list »

SymBiosis (Bentonville) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

SymBiosis (Bentonville) FAQs

  • What is SymBiosis (Bentonville)?

    Founded in 2021, SymBiosis is a venture capital firm based in Bentonville, Arkansas.

  • When was SymBiosis (Bentonville) founded?

    SymBiosis (Bentonville) was founded in 2021.

  • Where is SymBiosis (Bentonville) headquartered?

    SymBiosis (Bentonville) is headquartered in Bentonville, AR.

  • What is SymBiosis (Bentonville)'s total asset value?

    SymBiosis (Bentonville) has around in total assets under management.

  • How many investments has SymBiosis (Bentonville) made?

    SymBiosis (Bentonville) has made 68 investments.

  • What has SymBiosis (Bentonville) invested in?

    SymBiosis (Bentonville) has made numerous investments in companies like R1 Therapeutics, AdvanCell, and Alebund Pharmaceuticals within the Drug Discovery industry.

  • What has SymBiosis (Bentonville) invested in recently?

    SymBiosis (Bentonville)'s latest investment was on 30-Sep-2026 in R1 Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process